3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
46
Lymphoma, Large B-Cell, Diffuse
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lung Neoplasms
21
Leukemia, Myeloid, Acute
20
Burkitt Lymphoma
18
Hodgkin Disease
15
Recurrence
14
Lymphoma, Non-Hodgkin
14
Lymphoma
14
Carcinoma, Non-Small-Cell Lung
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Neuroblastoma
10
Lymphoma, Mantle-Cell
10
Lymphoma, B-Cell
10
Leukemia
10
Medulloblastoma
8
Neoplasms, Germ Cell and Embryonal
7
Neoplasms
7
Lymphoma, Follicular
7
Multiple Myeloma
6
Lymphoma, T-Cell
6
Brain Neoplasms
6
Sarcoma, Ewing
5
Retinoblastoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Immunoblastic Lymphadenopathy
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Interventions
durvalumab
13
Bevacizumab
11
Nivolumab
10
tremelimumab
7
pembrolizumab
6
lenvatinib
6
fludarabine
6
Cyclophosphamide
6
atezolizumab
4
Radiosurgery
4
Cisplatin
4
toripalimab
3
relatlimab
3
Magnetic Resonance Imaging
3
Ipilimumab
3
Gemcitabine
3
X-Rays
2
Standard of Care
2
Sorafenib
2
Riluzole
2
Radiotherapy
2
Photons
2
Patient Navigation
2
Lidocaine
2
Hepatectomy
2
Dexamethasone
2
Biopsy
2
trastuzumab deruxtecan
1
tocilizumab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Etoposide
×
1 year
×
Clear all
No trials found.